Abstract In general, tumor cells display a more glycolytic phenotype compared to the corresponding normal tissue. However, it is becoming increasingly clear that tumors are composed of a heterogeneous population of cells. Breast cancers are organized in a hierarchical manner, with the breast cancer stem cells (BCSCs) at the top of the hierarchy. Here, we investigate the metabolic phenotype of BCSCs and their differentiated progeny. In addition, we determine the effect of radiation on the metabolic state of these two cell populations. Luminal, basal, and claudin-low breast cancer cell lines were propagated as mammospheres enriched in BCSCs. Lactate production, glucose consumption, and ATP content were compared with differentiated cultures. A metabolic flux analyzer was used to determine the oxygen consumption, extracellular acidification rates, maximal mitochondria capacity, and mitochondrial proton leak. The effect of radiation treatment of the metabolic phenotype of each cell population was also determined. BCSCs consume more glucose, produce less lactate, and have higher ATP content compared to their differentiated progeny. BCSCs have higher maximum mitochondrial capacity and mitochondrial proton leak compared to their differentiated progeny. Radiation treatment enhances the higher energetic state of the BCSCs, while decreasing mitochondrial proton leak. Our study indicated that breast cancer cells are heterogeneous in their metabolic phenotypes and BCSCs reside in a distinct metabolic state compared to their differentiated progeny. BCSCs display a reliance on oxidative phosphorylation, while the more differentiated progeny displays a more glycolytic phenotype. Radiation treatment affects the metabolic state of BCSCs. We conclude that interfering with the metabolic requirements of BCSCs may prevent radiation-induced reprogramming of breast cancer cells during radiation therapy, thus improving treatment outcome.
Introduction
Radiation therapy is a key component of multimodal treatment concepts against localized breast cancer. If applied after breast conserving surgery, radiotherapy improves loco-regional control as well as overall survival [1] . Despite recent advances in breast cancer radiotherapy techniques and drug treatments, about 7 % of breast cancer patients still relapse loco-regionally indicating a need for further improvements [2] .
Recent pre-clinical and clinical data have confirmed the heterogeneity of cells within breast tumors. Prospective identification of highly tumorigenic subpopulations of breast cancer cells has supported a hierarchical organization of breast cancer and the existence of a small number of breast cancer stem cells (BCSCs) [3] . These BCSCs have the unique ability to self-renew indefinitely, regrow a breast tumor, and give rise to the different types of progeny found in the original tumor. Consequently, a successful anti-cancer therapy needs to eliminate all BCSCs in order to cure a patient [4] .
In the 1920s, Warburg et al. [5] reported that cancer cells, in contrast with most normal tissues, do not metabolize glucose mainly through oxidative phosphorylation, but rather through aerobic glycolysis (the ''Warburg effect''). Despite the fact that aerobic glycolysis is less efficient in producing ATP, and requires 16 times more glucose than oxidative phosphorylation to produce the same amount of ATP, it provides rapidly growing cancer cells with metabolites needed for the synthesis of macro-molecules during doubling of the cell mass during mitosis. This general difference between most cancer cells and normal cells has led to the development of PET imaging for visualization of metabolically active tumor cells [6] . Naturally, this profound difference in the metabolic state of cancer cells and normal cells has stirred interest in designing drugs that specifically target the aerobic glycolysis pathway.
We recently reported that BCSCs contain a large number of quiescent cells that lack the need for massive macromolecule synthesis. However, when exposed to ionizing radiation, quiescent BCSCs were redistributed into the cell cycle [7] . We have also reported that the bulk of the tumor cells in glioblastoma multiforme (GBM) differs in their metabolic requirements from GBM stem cells.
In the present report, we hypothesize that BCSCs would differ from their differentiated progeny with respect to their metabolic state and that irradiation would interfere with glucose metabolism in BCSCs.
Materials and methods

Cell culture
Human SUM159PT breast cancer cell line was purchased from Asterand (Detroit, MI). Human MCF-7, T47D, and MDA-MB-231 breast cancer cell lines were purchased from American Type Culture Collection (Manassas, VA). SUM159PT-ZsGreen-cODC, MCF-7-ZsGreen-cODC, T47D-ZsGreen-cODC, and MDA-MB-231-ZsGreen-cODC were obtained as described in Vlashi et al. [8] . SUM159PT cells were cultured in log-growth phase in F12 Medium (Invitrogen, Carlsbad, CA) supplemented with 5 % fetal bovine serum [Sigma Aldrich, St Louis, MO] and penicillin (100 U/mL) and streptomycin (100 lg/mL) cocktail [Invitrogen], 5 lg/mL insulin (Eli Lilly, Indianapolis, IN), and 1 lg/mL hydrocortisone (Pfizer, New York, NY). T47D and MDA-MD-231 cells were cultured in log-growth phase in Dulbecco's Modified Eagle Medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with 10 % fetal bovine serum and penicillin (100 U/mL) and streptomycin (100 lg/mL) cocktail. MCF7 cells were cultured in log-growth phase in Minimum Essential Media (MEM) Alpha (Invitrogen, Carlsbad, CA) supplemented with 10 % fetal bovine serum and penicillin (100 U/mL) and streptomycin (100 lg/mL) cocktail, non-essential amino acids (19) (NEAA, Invitrogen), 1 mM sodium pyruvate (Invitrogen), and 5 lg/mL insulin (Eli Lilly, Indianapolis, IN). All cells were grown in a humidified incubator at 37°C with 5 % CO 2 .
Oxygen consumption and extracellular acidification rate
The oxygen consumption and extracellular acidification rates of monolayers versus mammospheres were determined using the Seahorse XF Extracellular Flux Analyzer (Seahorse Bioscience Inc., North Billerica, MA). The Extracellular Flux Analyzer allows for analyzing oxygen consumption and extracellular acidification rates of a defined number of cells in a defined small volume of culture media in real-time and for monitoring their response to drug treatment. An overview of the technique has been previously described (11) . 24-well plates (Seahorse Bioscience Inc.) were coated with laminin (Sigma) as described previously in order to allow the single cells derived from mammosphere cultures to attach for this assay without differentiating [9] . Briefly, each well of the 24-well plate was coated with 50 lL laminin diluted in PBS (10 lg/mL) overnight. The next day, the wells were washed three times with PBS, and cells from monolayer or sphere cultures were plated at a density of 80,000 cells/ well and allowed to attach overnight in either monolayer or mammosphere media. The following day, the adherent cells were washed, and fresh media was added. The sensor cartridge was loaded to dispense three metabolic inhibitors sequentially at specific time points: oligomycin (inhibitor of ATP synthase, 1 lm), followed by FCCP (a protonophore and uncoupler of mitochondrial oxidative phosphorylation, 0.5 lm), followed by the addition of a combination of rotenone (mitochondrial complex I inhibitor, 1 lm) and myxothiazol (inhibitor of cytochrome C reductase, 100 nm). Basal oxygen consumption rate (OCR) and extracellular acidification rates (ECAR) were measured as well as the changes in oxygen consumption caused by the addition of the metabolic inhibitors described above. Several parameters were deducted from the changes in oxygen consumption, such as: basal OCR, maximum mitochondrial capacity, and mitochondrial reserve capacity [=(maximum mitochondrial capacity] -(basal OCR)] as described previously [10] (Supplementary Fig. 1a ).
Lactate production assays
The amount of lactate present in the media was estimated using the Lactate Assay Kit (BioVision Research Products) according to the manufacturer's instructions. The amount of lactate produced by the cells in each sample was calculated by subtracting the amount of lactate in the media (without cells) from the amount of lactate in the media from each sample.
Quantitative reverse transcription-PCR
Quantitative PCR was performed in the My iQ thermal cycler (Bio-Rad, Hercules, CA) using the 29 iQ SYBR Green Supermix (Bio-Rad). C t for each gene was determined, and DDC t was calculated relative to the designated reference sample. Gene expression values were then set equal to 2 -DDCt as described by the manufacturer of the kit (Applied Biosystems). PCR primers were synthesized by Invitrogen and designed for the human sequence of PFK_P, PFK_M, PFK_L, PKM1/2, and PKM1 (Forward primer: GAPDH (Forward primer: 5 0 -CGATCAACTCACCGCCAACA-3 0 , and Reverse primer:
0 , and Reverse primer: 5 0 -GATGACCAGCCCAAAGGA-GA-3 0 ) were used as loading control.
Irradiation
Cells grown as monolayers were sorted into ZsGreen-cODCneg and ZsGreen-cODC-pos cells and plated on laminin-coated Seahorse plates at 40,000 cells/well. The next day, the plates were irradiated at room temperature using an experimental X-ray irradiator (Gulmay Medical Inc. Atlanta, GA) at a dose rate of 2.789 Gy/min for the time required to apply a prescribed dose. Corresponding controls were sham irradiated.
Statistics
All data shown are represented as mean ± standard error mean (SEM) of at least 3 biologically independent experiments. A p value of B0.05 in a two-sided paired t test indicated a statistically significant difference.
Results
Breast cancer stem cells differ metabolically from their differentiated progeny
Recently, we reported that radiation treatment can reprogram breast cancer cells into BCSCs, and that these reprogramming events correlate with an increase in expression of reprogramming factors Oct4, Sox2, Nanog, and Klf4 [11] . In an attempt to determine whether BCSCs are affected by hypoxic conditions, we tested the reprogramming of breast cancer cells under hypoxic conditions versus normoxia. Propagating breast cancer cells as mammospheres is a common method for enriching the cell cultures for BCSCs. However, mammosphere cultures contain not only BCSCs but also differentiated cells. Therefore, we used an imaging system recently developed by our laboratory to sort BCSCs from non-tumorigenic cells using fluorescence activated cell sorting (FACS). This system takes advantage of the fact that BCSCs lack 26S proteasome activity and therefore, accumulates a fusion protein of ZsGreen and the C-terminal degron of ornithine decarboxylase (cODC). In cells with intact proteasome function, cODC directs the fusion protein to ubiquitinindependent proteasomal degradation. This allows for detection of BCSCs without the need for additional staining, which could potentially perturb metabolic function. We have demonstrated that this fluorescent reporter identifies breast cancer cells with a stem cell phenotype [7, 8, 11] and that breast cancer cells with low proteasome activity overlap with cells expressing high levels of ALDH1 and cells with a CD24 -/low / CD44 high phenotype, markers commonly used for identifying BCSCs [11] . Furthermore, more recent data indicate that breast cancer cells with low proteasome activity (ZsGreen-cODC-pos) are significantly more tumorigenic compared to the ZsGreen-cODC-neg cells [12] , and are necessary for tumor initiation and maintenance [13] . Initially, we characterized the intrinsic numbers of cells with low proteasome activity (ZsGreen-cODC-pos) in four different breast cancer cell lines: two luminal cell lines, MCF-7 and T47D, a basal cell line MDA-MB-231, and the claudin-low cell line, SUM159PT. The percentage of ZsGreen-cODC-pos cells increased in the more aggressive breast cancer lines, MDA-MB-231 and SUM159PT (Fig. 1a) . Next, we determined if the percentage of ZsGreen-cODC-pos cells in these lines is increased after a single dose of radiation treatment. As shown in Fig. 1b , radiation treatment indeed increases the number of BCSCs in a dose-dependent manner in all four cell lines tested. Motivated by recent reports demonstrating that BCSCs are stimulated in a hypoxic tumor microenvironment [14] , we investigated if hypoxic conditions further enhance the radiation-induced enrichment of BCSCs. To our surprise, hypoxic conditions partially prevented the radiation-induced enrichment of BCSCs (Fig. 1c) . These surprising results led us to hypothesize that the metabolism of BCSCs differs from that of the differentiated cells, given that hypoxic conditions affect the metabolism of a cell. In an attempt to acquire a better understanding of the metabolic state of BCSCs, we first compared lactate production levels in all four breast cancer lines. Cells were seeded at clonal densities into ultra-low adhesion plates under serum-free conditions to allow formation of mammospheres and to enrich for BCSCs [15] . Lactate production from mammosphere cultures was compared to the corresponding differentiated cells cultured as monolayers. Lactate production was significantly decreased under mammosphere conditions that favor selection for BCSCs (Fig. 2a ). Next, we tested if these results correlated with glucose uptake. Interestingly, mammosphere cultures utilized significantly more glucose than the differentiated monolayer cultures (Fig. 2b, c) . In order to determine whether there was a qualitative difference in functional mitochondria in the BCSC population in these cell lines compared to the differentiated cells, we labeled the mitochondria of all the cell lines expressing the ZsGreen-cODC reporter for BCSCs, with a mitochondria-specific redfluorescent dye (MitoTracker CMXRos) and analyzed the mitochondria-associated fluorescence via Flow Cytometry. When the ZsGreen-cODC-pos population was compared to ZsGreen-cODC-neg population of cells in mammosphere cultures of all four cell lines, the mitochondria-specific dye consistently labeled the BCSCs (ZsGreen-cODC-pos) more efficiently than the non-stem cell (ZsGreen-cODC-neg) population (Fig. 2d) . These results suggested that BCSCs may have a greater number of mitochondria. However, it should be noted that the accumulation of the red-fluorescent MitoTracker Red CMXRos depends on the mitochondrial membrane potential. Therefore, the latter results could alternatively suggest that BCSCs have more efficient mitochondria thus, making them more efficient at performing oxidative phosphorylation. Finally, we measured the ATP content of cells propagated in mammosphere cultures, and found that they had more than a twofold increase in ATP content compared to the monolayer cultures (Fig. 2e) . Taken together, these results suggested that 
Breast cancer stem cells up-regulate phosphofructokinase
In an attempt to explore the underlying mechanism of the observed differences between the bulk of the breast cancer cells and BCSCs, we measured the gene expression levels of two pyruvate kinase muscle isozymes-PK-M1 and PK-M2-key enzymes that have been implicated in the Warburg effect [16, 17] . Surprisingly, we were not able to detect differences in the expression levels of both enzymes between BCSCs and non-tumorigenic cells, in a luminal breast cancer line (MCF7) and the claudin-low line (SUM159PT) (Fig. 3a) .
However, a recent study demonstrated a link between the platelet isoform of the glycolytic enzyme, phosphofructokinase (PFK-P) ,and KLF4, a transcription factor important in maintaining stemness, as well as in reprogramming of somatic cells into iPSCs [18] . In these studies, it was demonstrated that in breast cancer cells, KLF4 activates the transcription of the PFK-P gene directly by binding to its promoter [19] . To investigate the expression of the PFK gene in our system, we performed qRT-PCR analysis in two different breast cancer lines in sorted differentiated cells (ZsGreen-cODC-neg) and sorted BCSCs (ZsGreen-cODC-pos). In both cases, two isoforms of the PFK1 enzyme were upregulated in the ZsGreencODC-pos population compared to the ZsGreen-cODC-neg population in the luminal breast cancer line, T47D and the claudin-low line, SUM159PT (Fig. 3b) .
Next, in order to determine whether the glucose molecules committed to glycolysis are oxidized all the way to lactate or are shuttled into the mitochondria for oxidative phosphorylation, we measured OCR in the SUM159PT-ZsGreen-cODC-pos cells versus ZsGreen-cODC-neg cells using a metabolic flux analyzer. Indeed, if left undisturbed the ZsGreen-cODC-pos BCSC population consumed more oxygen compared to the ZsGreen-cODC-neg population ( Fig. 3c) . Finally, when the extracellular acidification rate was plotted against OCR for BCSCs and non-tumorigenic cells, BCSCs were more energetic than their non-tumorigenic progeny (Fig. 3d) .
Effect of radiation treatment on the metabolic state of BCSCs
Next, we sought to examine the metabolic state of BCSCs more quantitatively using the metabolic flux analyzer and the addition of a series of metabolic inhibitors, as described previously ( Supplementary Fig. 1a ) [20] . These experiments revealed that BCSCs and non-tumorigenic cells did not differ in ATP turnover, mitochondrial reserve capacity, or non-mitochondrial respiration ( Supplementary Fig. 1b) . However, BCSCs showed a significant increase in maximum mitochondrial capacity and mitochondrial proton leak (Fig. 4a) . In general, maximal mitochondrial capacity is associated with mitochondria content; therefore, these results are in line with our observations that BCSCs have higher number of mitochondria (Fig. 2d) . These results indicated again that BCSCs depend more on oxidative phosphorylation.
We have recently reported that ionizing radiation reprogrammed non-tumorigenic breast cancer cells into induced BCSCs (induced-BCSCs) [11] . This reprogramming step was mediated by radiation-induced re-expression of the embryonic stem cell transcription factors Oct4, Sox2, Nanog, and Klf4 [11] , and our data indicate that induced-BCSCs could be a major cause for treatment failure [11] . Interestingly, irradiation with a single dose of 8 Gy significantly enhanced the more energetic phenotype of BCSCs in an acute manner (30 min post irradiation exposure), while the metabolic state of non-tumorigenic cells was not affected by radiation treatment (Fig. 4b) . Further analysis demonstrated that radiation treatment with a single dose of 8 Gy did not have an effect on the maximum mitochondrial capacity of non-tumorigenic cells or BCSCs (Fig. 4c, left panel) ; however, it significantly reduced the mitochondrial proton leak for both cell populations (Fig. 4c, right panel) . Although surprising, these results indicate that radiation treatment restores mitochondrial membrane potential, thus improving oxidative phosphorylation efficiency in the ZsGreen-cODC-population, and making this population of cells more energetic, as shown in Fig. 4b . 
Discussion
The Warburg effect is one of the most striking differences observed between normal tissues and tumors. The increased glucose uptake in tumors is now effectively used in PET imaging in oncology for tumor detection and response to therapy. More recently, targeting metabolic pathways that confer cancer cells a survival advantage has become an area of increasing interest. The hope that metabolic differences between cancer cells and normal tissue will offer opportunities for therapeutic intervention is experiencing a rebirth since Warburg first described the unique metabolic state of cancer cells [21] .
Pre-clinical and clinical data support a hierarchical organization of solid cancers with a small population of radiotherapy-and chemotherapy-resistant cancer stem cells that exhibit increased self-renewal capacity and the ability to regrow a tumor after sublethal treatment. In breast cancer and glioma, a significant number CSCs are quiescent and only recruited into the pool of cycling cells during the repopulation of the tumor [7, 8] . The quiescent state of a cell is considered a catabolic state and associated with autophagy, suggesting that the metabolic pathways utilized in CSCs may differ from those in differentiated cells. We have previously reported that in glioma this is indeed the case [20] . Lagadinou et al. [22] have reported similar results in leukemia, and were able to use the dependency of quiescent leukemia stem cells on mitochondrial metabolism for their elimination.
Here, we report that, similar to glioma, BCSCs also depend more on oxidative phosphorylation for their energy needs. The experimental evidence suggesting that BCSCs depend more on oxidative phosphorylation are severalfold. BCSCs, (1) produce less lactate than their differentiated progeny (Fig. 2a) , (2) have a higher number of mitochondria or more functional mitochondria (as determined by the mitochondria-specific fluorescent stain MitoTracker RED CMXRos (Fig. 2d) ), and (3) have higher ATP content (Fig. 2e ), which correlates with higher OCR (Fig. 3c) , and a more energetic state (Fig. 3d) (Scheme 1) . Interestingly, to our surprise, BCSCs in our system also consumed more glucose than their differentiated counterparts (Fig. 2b, c) behaving more like a cell with a glycolytic phenotype. However, while there was no difference in relative Fig. 4 Radiation treatment changes the metabolic phenotype of breast cancer stem cells. Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were measured in sorted SUM159-ZsGreen-cODC-neg and SUM159-ZsGreen-cODC-pos cells in the absence and presence of a series of metabolic inhibitors as described in Vlashi et al. [20] . Maximum mitochondrial capacity and mitochondrial proton leak were calculated, and both these parameters were significantly higher in the BCSCs (ZsGreen-pos) compared to the non-tumorigenic cells (a). b A single dose of 8 Gy enhanced the energetic state of BCSCs (ZsGreen-pos), but it had no effect on the ZsGreen-neg population. expression of the M1 and M2 isoforms of pyruvate kinase, a glycolytic enzyme that has been implicated in the Warburg effect [16] , there was a significant difference in the relative expression of the phosphofructokinase (PFK)-P and L isoforms. PFK is a glycolytic enzyme that mediates a commitment step in glycolysis. Therefore, taken together these results indicate that BCSCs are not only taking up more glucose and are committing more of it down the glycolytic pathway, but are also shuttling more of the resulting pyruvate into the mitochondria, as indicated by the lower lactate production and increased OCR, mitochondrial numbers/mass and ATP content in BCSCs compared to their differentiated progeny (Scheme 1). Previously, we have reported that GBM stem cells exhibited higher lactate production, less glucose consumption, and lower extracellular acidification rate [20] -results that seem contradictory to the findings reported here for BCSCs. It should be noted that lactate production levels in the current study were measured in breast cancer cells propagated in differentiation media (as monolayers) and compared to cultures propagated as mammospheres enriched in BCSCs. In contrast, the GBM stem cell study compared ZsGreen-cODC-neg and ZsGreen-cODC-pos cells sorted from neurosphere cultures enriched in GBMSCs, thus these two data sets cannot be directly compared and do not necessarily contradict each other. In the case of glucose consumption, both studies (in breast and GBM) compared differentiated cultures (monolayers) with CSCenriched cultures (mammospheres in breast, and neurospheres for GBM). However, we indeed observed opposite results, as mammosphere cultures had higher glucose uptake compared to their differentiated cultures, glioma neurosphere cultures consumed less glucose than the corresponding differentiated glioma cultures. Such a discrepancy cannot readily be explained, and further studies on levels of glucose transporters would be needed to shed light on these observed differences.
We recently reported that BCSCs, identified by our fluorescent reporter system, express higher levels of the Yamanaka transcription factors [18] responsible for inducing pluripotent stem cells (iPS) from differentiated cells [11] , including Krüppel-like Factor (KLF4). Interestingly, a recent report demonstrates that KLF4 activates the transcription gene for the platelet isoform of phosphofructokinase (PFK-P) in breast cancer [19] . The specific up-regulation of the PFK-P enzyme in the BCSC population diverts most of the glucose away from the pentose phosphate shunt, which feeds into nucleotide synthesis. We have also previously demonstrated that the BCSCs with low proteasome activity exhibit a quiescent phenotype [7] , and thus do not have a need for efficient nucleotide synthesis required for rapid proliferation. Furthermore, in general, cells that are not proliferating depend more on oxidative phosphorylation, and only switch to glycolysis upon requirements for rapid proliferation [23] , which is consistent with our findings. One of the most interesting findings resulting from these studies was the observation that radiation treatment pushes BCSCs into a more energetic state, while the non-stem cell population remains undisturbed. Further studies are necessary to shed light into the possible mechanisms for such a differential effect of radiation treatment on the metabolic state of BCSCs and the non-stem cell compartment of breast tumors.
In summary, our data have important implications in the context of studies aiming at targeting tumor cell metabolism, while considering tumors as a bulk population of Scheme 1 BCSCs consume more glucose and commit more of it down the glycolytic pathway by upregulating PFK1. Pyruvate is further oxidized in mitochondria resulting in higher oxygen consumption and ATP content, and lower lactate production cells. We have now demonstrated via two different tumor models, previously in GBM [20] and presently in breast cancer that cancer stem cells populations, within solid tumors that have a hierarchical organization, differ in their metabolic state from the differentiated progeny. Our studies demonstrate that BCSCs rely more on oxidative phosphorylation than glycolysis when compared to their more differentiated counterparts. The findings presented here add to the body of literature on the metabolic state of cancer stem cells. Other laboratories have reported metabolic differences in the tumor initiating cell population for different solid tumors [24] [25] [26] , and there is contradicting evidence on the metabolic state of BCSCs [27] . It is evident that more studies are needed to further characterize the metabolic state of cancer stem cells to clearly define whether interference with the metabolic requirements of this important cancer cell population will translate into therapeutic benefit for cancer patients.
